Piramal Pharma Limited Announces Results for Q2 and H1 FY25 Oct 23, 2024 02:01PM
Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, 'Building Resilience for a Sustainable Tomorrow' Oct 4, 2024 06:43AM
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky Sep 30, 2024 10:35AM
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work Jul 30, 2024 07:55AM
Piramal Pharma Limited Announces Consolidated Results for Q1FY25 Jul 26, 2024 06:45AM


Oct 28, 2023 07:09AM Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
Aug 3, 2023 06:28PM Piramal Pharma Limited Announces Consolidated Results for Q1FY24
Mar 30, 2023 04:02AM PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN
Feb 15, 2023 10:32AM PIRAMAL PHARMA SOLUTIONS ANNOUNCES PRODUCTION OF FIRST BATCHES AT NEW API FACILITY IN RIVERVIEW, MICHIGAN